NBMC Gap Analysis Workshop AFRL Perspective
Abstract:
Nano-bio materials are driving innovation with significant potential to enhance the capabilities of the U.S. Air Force. From lightweight materials and advanced coatings to environmental sensors, biosensors, energy harvesting, and biomedical applications, these materials offer solutions to critical operational challenges, such as improving Airmen's health, protecting assets, and optimizing aerospace systems. The Air Force Research Laboratory’s Nano-Bio Materials Consortium (NBMC) plays a pivotal role in translating these innovations into practical applications by connecting technology developers with Air Force customers. AFRL’s unique position allows it to align research with the operational needs of Airmen, ensuring that innovations meet mission requirements. Through de-risking and accelerating commercialization, AFRL facilitates the development of biomaterials and biomedical technologies that benefit both military and public sectors. Additionally, AFRL supports co-development efforts, fostering collaboration with industry and academia, and providing access to world-class research facilities and expertise. Gap analysis within the NBMC identifies key opportunities in nano-bio material technologies, medical monitoring, and augmentation, helping the Air Force stay at the forefront of technological advancements. By addressing these gaps, nano-bio materials are poised to enhance defense capabilities while delivering broad societal benefits.
Biography:
Dr. Leila Safa is a Research Scientist at the Biomaterials Branch (RXEB) within the Materials and Manufacturing Directorate at the Air Force Research Laboratory. She also serves as the Technology Transfer Lead at RXEB and as the Government Program Manager for the Nano-Bio Materials Consortium (NBMC), in addition to being a member of the NBMC Technical Committee. She brings a strong technical background in surface chemistry, and biosensor development, with experience across both startup and corporate settings. She began her career as Principal Scientist and Sensor Development Team Lead at Eccrine Systems, a wearable sensor company specializing in advanced sweat sensing technology. Dr. Safa then joined GE Research Center as a Research Scientist, where she contributed to the development of a variety of biosensor platforms. Later, as Director of Research and Analytics at Vigilife, she led research efforts, generated insights, and developed regulatory strategies.